1375 related articles for article (PubMed ID: 25752327)
1. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.
Park JW; Chen M; Colombo M; Roberts LR; Schwartz M; Chen PJ; Kudo M; Johnson P; Wagner S; Orsini LS; Sherman M
Liver Int; 2015 Sep; 35(9):2155-66. PubMed ID: 25752327
[TBL] [Abstract][Full Text] [Related]
2. Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study.
Kudo M; Lencioni R; Marrero JA; Venook AP; Bronowicki JP; Chen XP; Dagher L; Furuse J; Geschwind JF; Ladrón de Guevara L; Papandreou C; Sanyal AJ; Takayama T; Yoon SK; Nakajima K; Lehr R; Heldner S; Ye SL
Liver Int; 2016 Aug; 36(8):1196-205. PubMed ID: 26901163
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma: an Asian perspective.
Teo EK; Fock KM
Dig Dis; 2001; 19(4):263-8. PubMed ID: 11935085
[TBL] [Abstract][Full Text] [Related]
4. Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma.
Chen M; Therneau T; Orsini LS; Qiao YL
BMC Gastroenterol; 2011 May; 11():53. PubMed ID: 21569429
[TBL] [Abstract][Full Text] [Related]
5. Demographic, clinical, and virological characteristics of hepatocellular carcinoma in Asia: survey of 414 patients from four countries.
Wang BE; Ma WM; Sulaiman A; Noer S; Sumoharjo S; Sumarsidi D; Tandon BN; Nakao K; Mishiro S; Miyakawa Y; Akahane Y; Suzuki H
J Med Virol; 2002 Jul; 67(3):394-400. PubMed ID: 12116033
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy.
Debes JD; Chan AJ; Balderramo D; Kikuchi L; Gonzalez Ballerga E; Prieto JE; Tapias M; Idrovo V; Davalos MB; Cairo F; Barreyro FJ; Paredes S; Hernandez N; Avendaño K; Diaz Ferrer J; Yang JD; Carrera E; Garcia JA; Mattos AZ; Hirsch BS; Gonçalves PT; Carrilho FJ; Roberts LR
Liver Int; 2018 Jan; 38(1):136-143. PubMed ID: 28640517
[TBL] [Abstract][Full Text] [Related]
7. Global trends and predictions in hepatocellular carcinoma mortality.
Bertuccio P; Turati F; Carioli G; Rodriguez T; La Vecchia C; Malvezzi M; Negri E
J Hepatol; 2017 Aug; 67(2):302-309. PubMed ID: 28336466
[TBL] [Abstract][Full Text] [Related]
8. Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques.
Young S; Craig P; Golzarian J
Eur Radiol; 2019 Jun; 29(6):3287-3295. PubMed ID: 30350163
[TBL] [Abstract][Full Text] [Related]
9. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
[TBL] [Abstract][Full Text] [Related]
10. The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years?
Yim SY; Seo YS; Jung CH; Kim TH; Lee JM; Kim ES; Keum B; Jong YK; An H; Kim JH; Yim HJ; Kim DS; Jeen YT; Yeon JE; Lee HS; Chun HJ; Byun KS; Um SH; Kim CD; Ryu HS
Liver Int; 2016 Mar; 36(3):445-53. PubMed ID: 26352789
[TBL] [Abstract][Full Text] [Related]
11. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
[TBL] [Abstract][Full Text] [Related]
12. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma downstaging in liver transplantation.
Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
[TBL] [Abstract][Full Text] [Related]
14. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
15. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S; Rhim H; Kim YS; Kang TW; Song KD
Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
[TBL] [Abstract][Full Text] [Related]
16. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.
McGlynn KA; Petrick JL; London WT
Clin Liver Dis; 2015 May; 19(2):223-38. PubMed ID: 25921660
[TBL] [Abstract][Full Text] [Related]
17. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.
Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY
Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297
[TBL] [Abstract][Full Text] [Related]
18. CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement.
Zhao M; Wang JP; Pan CC; Li W; Huang ZL; Zhang L; Fang WJ; Jiang Y; Li XS; Wu PH
Eur J Radiol; 2012 Oct; 81(10):2717-25. PubMed ID: 22245655
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
[TBL] [Abstract][Full Text] [Related]
20. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
